University of Michigan

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Michigan</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>University of Michigan</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Ann Arbor, Michigan, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Research University</td>
</tr>
<tr>
<td class="label">Established</td>
<td>1817</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.umich.edu/" target="_blank">https://www.umich.edu/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [Neuroscience](/mechanisms), [Neuroinflammation](/mechanisms/neuroinflammation)</td>
</tr>
<tr>
<td class="label">Departments</td>
<td>Department of Neurology, Michigan Neuroscience Institute, Institute for Clinical and Translational Research</td>
</tr>
<tr>
<td class="label">Medical School Ranking</td>
<td>Top 15 (US News & World Report)</td>
</tr>
<tr>
<td class="label">Research Funding</td>
<td>$1.5B+ annually</td>
</tr>
</table>

University of Michigan

Overview

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Michigan</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>University of Michigan</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Ann Arbor, Michigan, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Research University</td>
</tr>
<tr>
<td class="label">Established</td>
<td>1817</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.umich.edu/" target="_blank">https://www.umich.edu/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [Neuroscience](/mechanisms), [Neuroinflammation](/mechanisms/neuroinflammation)</td>
</tr>
<tr>
<td class="label">Departments</td>
<td>Department of Neurology, Michigan Neuroscience Institute, Institute for Clinical and Translational Research</td>
</tr>
<tr>
<td class="label">Medical School Ranking</td>
<td>Top 15 (US News & World Report)</td>
</tr>
<tr>
<td class="label">Research Funding</td>
<td>$1.5B+ annually</td>
</tr>
</table>

University of Michigan

Overview

University of Michigan is a premier public research university located in Ann Arbor, Michigan, founded in 1817[@university2026]. It is one of the leading research institutions in the United States and has established particular excellence in neuroscience and neurodegenerative disease research. The university is recognized for comprehensive programs in [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), and [neuroinflammation](/mechanisms/neuroinflammation).

The University of Michigan maintains multiple world-class research centers dedicated to neurodegeneration, including the Department of Neurology and the Michigan Neuroscience Institute["@michigan2026"]. These centers bring together basic scientists and clinical researchers to advance understanding and treatment of neurological disorders.

The university has a distinguished history in medical research, with the Medical School established in 1850. Today, it ranks among the top 15 medical schools in the United States and attracts over $1.5 billion in annual research funding. The neuroscience research program is particularly strong, with investigators making fundamental contributions to understanding Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders.

History and Institutional Background

The University of Michigan is one of the original public universities in the United States and has been at the forefront of medical research for over two centuries. The Medical School was established in 1850 and has since become one of the leading medical research institutions in the country.

The Michigan Neuroscience Institute was established to consolidate the university's neuroscience research efforts and has become a hub for innovative research on brain disorders. The institute brings together investigators from multiple departments and schools, fostering interdisciplinary collaboration that has yielded significant advances in understanding neurodegenerative diseases.

Key Historical Milestones

• 1817: University of Michigan founded
• 1850: Medical School established
• 1950s: Department of Neurology established
• 1980s: Alzheimer's disease research program initiated
• 2000: Michigan Neuroscience Institute founded
• 2010: Parkinson's Foundation Center of Excellence designated
• 2015: NIH Alzheimer's Disease Research Center awarded
• 2020: ALS Center of Excellence established

Research Programs

Focus Areas

The University of Michigan conducts comprehensive research across multiple neurodegenerative disease areas:

• [Alzheimer's Disease](/diseases/alzheimers-disease) and related dementias
• [Parkinson's Disease](/diseases/parkinsons-disease) and movement disorders
• [Amyotrophic Lateral Sclerosis (ALS)/Motor Neuron Disease](/diseases/als)
• [Multiple Sclerosis](/diseases/multiple-sclerosis)
• [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
• [Dementia with Lewy Bodies](/diseases/dementia-with-lewy-bodies)
• [Neuroinflammation](/mechanisms/neuroinflammation) and microglia biology
• [Cognitive Decline](/mechanisms) and aging

Departments and Centers

The university hosts numerous specialized research units:

• Department of Neurology: Comprehensive clinical and research programs across all neurological disorders
• Michigan Neuroscience Institute: Basic neuroscience research and training
• Institute for Clinical and Translational Research: Translation of discoveries to clinical applications
• Alzheimer's Disease Research Center: NIH-funded comprehensive dementia research program
• Parkinson's Disease Research Center: Movement disorders research and clinical care
• ALS Center of Excellence: Comprehensive ALS care and research program
• Stem Cell Research Program: Induced pluripotent stem cell modeling of disease

Major Research Initiatives

Key Research Themes

Alzheimer's Disease Research

Michigan researchers lead major initiatives in biomarker development, clinical trials, and disease mechanism research[@jack2018][@scheltens2018]:

Biomarker Development:

• Cerebrospinal fluid biomarkers (Aβ42, tau, p-tau)
• Blood-based biomarkers (p-tau181, p-tau217, NfL)
• PET amyloid and tau imaging
• Digital biomarkers and remote monitoring

• Anti-amyloid therapies (lecanemab, donanemab)
• Anti-tau therapies
• Disease-modifying treatments
• Prevention trials in at-risk populations

• Amyloid and tau pathology
• [APOE](/genes/apoe) genetics and biology
• Neuroinflammation and microglia
• Synaptic dysfunction

Parkinson's Disease Research

The university has a robust PD research program with expertise across multiple domains[@dodel2020][@siderowf2019][@lees2022]:

Alpha-Synuclein Biology[@chen2023]:

• Protein aggregation mechanisms
• Prion-like propagation
• Cellular clearance pathways
• Strain characterization

• LRRK2 pathobiology and function
• Kinase inhibitor development
• Genetic modifiers of LRRK2 penetrance
• Cell biology of LRRK2 mutations

• Deep brain stimulation outcomes[@kalia2019]
• Non-motor symptoms management[@weintraub2019]
• Biomarker development[@poston2022]
• Clinical trial design and execution[@jankovic2023]

• Microglial activation states[@swanson2019]
• Inflammatory biomarker discovery
• Therapeutic targeting of neuroinflammation

ALS and Motor Neuron Disease

The ALS Center of Excellence conducts:

• Genetic testing and counseling
• Clinical trials for disease-modifying therapies
• Biomarker development
• Patient care and support services

Notable Faculty and Leadership

The University of Michigan brings together leading researchers in neurodegeneration:

Key Investigators

• Dr. Nancy K. ip — Alzheimer's disease biomarkers and clinical trials
• Dr. Roger L. Albin, MD — Parkinson's disease mechanisms and therapy development
• Dr. Kirk R. D. , MD — Movement disorders and deep brain stimulation
• Dr. Benjamin L. , PhD — Neuroinflammation and microglia biology
• Dr. Eva L. , PhD — Protein aggregation in neurodegeneration
• Dr. Martijn L. , PhD — Alpha-synuclein biology
• Dr. Werner H. , MD, PhD — Clinical trials and drug development

Clinical Leadership

• Movement Disorders Program Director
• Memory Disorders Clinic Director
• ALS Clinic Director
• Multiple Sclerosis Center Director

Research Infrastructure

Clinical Research Facilities

• Michigan Clinical Research Unit: Outpatient research facility
• Clinical Trial Center: Early-phase clinical trials
• Memory Disorders Clinic: Comprehensive dementia evaluation
• Movement Disorder Clinic: Advanced Parkinson care

Basic Research Facilities

• Advanced Imaging Center: 7T MRI, PET/CT, PET/MRI
• Stem Cell Core: iPSC generation and differentiation
• Animal Models Facility: Transgenic and knockout mouse models
• Microscopy Core: Confocal, electron microscopy
• Flow Cytometry Core: Cell sorting and analysis
• Genomics Core: Sequencing and genomic analysis

Data Science Resources

• Clinical data registry
• Neuroimaging database
• Biospecimen repository
• Machine learning and AI infrastructure

Major Contributions to the Field

Biomarker Development

The university has contributed significantly to biomarker research:

Clinical Trials

Michigan researchers have led numerous pivotal trials:

Disease Mechanisms

Key discoveries include:

Training and Education

Residency and Fellowship Programs

• Neurology residency (ACGME-accredited)
• Movement Disorders Fellowship
• Memory Disorders/Neuropsychiatry Fellowship
• Clinical Neurophysiology Fellowship
• Multiple Sclerosis Fellowship

Graduate Programs

• PhD in Neuroscience
• PhD in Biomedical Engineering
• MD/PhD program
• Postdoctoral training programs

Continuing Education

• Annual neuroscience symposium
• Visiting professor series
• Clinical update courses

Collaborations and Partnerships

National Collaborations

• National Institute on Aging (NIA)
• Michael J. Fox Foundation for Parkinson's Research
• ALS Association
• Alzheimer's Association
• Parkinson's Foundation

International Partnerships

• International Parkinson's Disease Genetics Consortium
• Alzheimer's Disease Neuroimaging Initiative (ADNI)
• Global Parkinson's Genetics Program (GP2)

Industry Partnerships

• Pharmaceutical companies for clinical trials
• Biotechnology companies for drug development
• Medical device companies for therapeutic devices

Future Directions

The university is pursuing several strategic research priorities:

External Links

• Official Website: [https://www.umich.edu/](https://www.umich.edu/)
• Michigan Neuroscience Institute: [https://medicine.umich.edu/neurology](https://medicine.umich.edu/neurology)
• Michigan Medicine: [https://medicine.umich.edu/](https://medicine.umich.edu/)
• Alzheimer's Disease Research Center: [https://alzheimers.med.umich.edu/](https://alzheimers.med.umich.edu/)

Related Pages

• [Alzheimer's Disease Research Centers](/institutions/)
• [Parkinson's Disease Research Centers](/institutions/)
• [Michigan Neuroscience Institute](/institutions/)
• [APOE Gene](/genes/apoe)
• [LRRK2 Gene](/genes/lrrk2)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [Neuroinflammation](/mechanisms/neuroinflammation)

See Also

• [Researchers and Institutions Index](/researchers)
• [Diseases Index](/diseases)
• [Mechanisms Index](/mechanisms)
• [US Neuroscience Research](/institutions/)
• [Clinical Trials](/therapeutics/)

References